Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90 — Stella

Home/Hepatocellular Carcinoma (HCC)/Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90

View on ClinicalTrials.gov

Recruiting

Back to Hepatocellular Carcinoma (HCC) trials

Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90

Trial locations(1 site)

United States

VA Palo Alto Health Care System, Palo Alto, California

Key details

Sponsor

Palo Alto Veterans Institute for Research

Enrollment target

~12 participants

Started

August 2024

Primary completion

August 2026

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.